MBIO NASDAQ
Mustang Bio, Inc.
1W: -9.5%
1M: -13.2%
3M: -33.6%
YTD: -56.0%
1Y: -70.0%
3Y: -99.5%
5Y: -100.0%
$0.47
+0.00 (+0.83%)
Weekly Expected Move ±7.4%
$0
$0
$0
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
13 relationships13
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2023-05-22
Earliest Filing
2025-02-27
Latest Filing
acquirer: 5
partner: 5
supplier: 2
customer: 1
Counterparties (Filed by MBIO)
13 relationshipsCompanies named in MBIO's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| AbbVie Bioresearch Center Inc. | ABBV | acquirer | Purchased FF&E and leased premises from Mustang Bio, Inc. | 2025-02-27 | View |
| WCS - 377 Plantation Street, Inc. | — | partner | Landlord of the premises leased by Mustang Bio, Inc. | 2025-02-27 | View |
| AbbVie Bioresearch Center Inc. | ABBV | customer | Purchased FF&E and assumed lease of premises from Mustang Bio, Inc. | 2025-02-13 | View |
| WCS - 377 Plantation Street, Inc. | — | supplier | Landlord of the premises leased by Mustang Bio, Inc. | 2025-02-13 | View |
| uBriGene (Boston) Biosciences, Inc. | — | acquirer | Counterparty in asset purchase and repurchase agreements regarding cell processing facility assets. | 2024-07-03 | View |
| uBriGene (Boston) Biosciences, Inc. | — | acquirer | Acquired Mustang Bio's Worcester cell processing facility and associated assets | 2023-07-31 | View |
| WCS-377 Plantation Street, Inc. | — | partner | Landlord of the Worcester facility lease | 2023-07-31 | View |
| The Paul Revere Life Insurance Company | — | supplier | Sublessor providing office space and tenant improvement allowance under a sublease agreement. | 2023-07-20 | View |
| uBriGene (Boston) Biosciences, Inc. | — | acquirer | Agreement to purchase Mustang Bio's leasehold interest in cell processing facility and associated assets. | 2023-06-30 | View |
| uBriGene (Boston) Biosciences, Inc. | — | acquirer | Acquired Mustang Bio's Worcester cell processing facility and associated assets for $11 million. | 2023-05-22 | View |
| UBrigene (Jiangsu) Biosciences Co., Ltd. | — | partner | Parent company of uBriGene (Boston) Biosciences, Inc. | 2023-05-22 | View |
| City of Hope National Medical Center | — | partner | Partnered with Mustang Bio on CAR T therapy programs; agreements terminated. | 2023-05-22 | View |
| St. Jude Children's Research Hospital, Inc. | — | partner | Licensed gene therapy technology to Mustang Bio; clinical trials paused. | 2023-05-22 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-04-17 | Delisting Notice | View | |
| 2025-12-23 | Submission of Matters to a Vote of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2025-07-09 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-05 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-27 | Completion of Acquisition or Disposition of Assets; Other Events; Financial Statements and Exhibits | Acquisition | View |
| 2025-02-21 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-02-13 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement | Agreement | View |
| 2025-02-11 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-01-17 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-01-10 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-01-02 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-11-15 | Notice of Delisting or Transfer; Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-06 | Shareholder Nominations; Other Events | View | |
| 2024-10-25 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Departure/Electio | Agreement | View |
| 2024-09-13 | Notice of Delisting or Transfer | View | |
| 2024-07-03 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Completion o | Agreement Acquisition | View |
| 2024-06-24 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2024-05-21 | Notice of Delisting or Transfer; Other Events | View | |
| 2024-04-29 | Results of Operations and Financial Condition | View | |
| 2024-04-12 | Costs Associated with Exit or Disposal Activities | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR